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• Several insulin infusion protocols have been 
developed to maintain glycaemia levels within 
normal limits during and after cardiac surgery with 
cardiopulmonary bypass (CPB). 
• We developed an easy applicable protocol 
(University of Ghent Insulin Protocol or UGIP) for 
achieving a glucose level between 70 and 180 
mg/dL during cardiac surgery.  
 
• Start a continuous infusion of insulin after 
induction of anaesthesia at a calculated rate in 
units per hour: 
 - non-diabetic patients: glycaemia divided by 75 
    = units per hour. 
 - diabetic patients: glycaemia divided by 50 
    = units per hour. 
• This maintenance dose is doubled when 
rewarming is started during CPB. 
• The initial dose is reinstituted after protamine 
administration. 
• 776 cardiac surgery patients with and without pre-
existing diabetes mellitus were treated with UGIP. 
• Perioperative glycaemia levels were analysed 
using analysis of variance for repeated    
measurements. 
• Effectiveness of treatment was assessed by 
comparing baseline glycaemia values to the 
values at  the end of surgery. Backward stepwise 
regression analysis identified the independent 
variables associated with deviation of baseline 
glycaemia values. 
• Data are expressed as mean ± standard 
deviation. 
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All Patients (n=776) 
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Diabetics (n=111) 
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Non-Diabetics (n=665) 
• Difference between glycaemia at baseline and at 
the end of the operation was 6 ± 50 mg/dL (110 
± 45 vs 116 ± 30, p = 0.001).  
• Age > 70 years (p = 0.025), use of corticosteroids 
(p = 0.002) and the presence of diabetes mellitus 
(p < 0.001) were identified as independent risk 
factors for changes in perioperative glycaemia. 
Conclusion  
• UGIP preserved perioperative blood glucose levels within narrow limits.  
• Risk factors for important deviation of pre-induction glycaemia were the presence of 
diabetes mellitus, the use of corticosteroids and age > 70 years. 
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